Mortality risk from comorbidities independent of triple-negative breast cancer status: NCI-SEER-based cohort analysis
Swede H, Sarwar A, Magge A, Braithwaite D, Cook LS, Gregorio DI, Jones BA, R. Hoag J, Gonsalves L, L. Salner A, Zarfos K, Andemariam B, Stevens RG, G. Dugan A, Pensa M, A. Brockmeyer J. Mortality risk from comorbidities independent of triple-negative breast cancer status: NCI-SEER-based cohort analysis. Cancer Causes & Control 2016, 27: 627-636. PMID: 27000206, PMCID: PMC5591028, DOI: 10.1007/s10552-016-0736-3.Peer-Reviewed Original ResearchConceptsCharlson co-morbidity indexRisk of deathBreast cancer patientsB patientsCCI scoreHazard ratioCancer patientsTriple-negative breast cancer subtypeTriple-negative breast cancer statusWhite breast cancer patientsCo-morbidity indexConnecticut Tumor RegistryEstimated hazard ratioBreast cancer statusBreast cancer subtypesAA/BCause mortalityClinicopathological factorsTumor RegistryAmerican/BlackCancer populationHigh prevalenceBreast cancerCohort analysisCancer status